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Introduction 
A new transient form of hyperphenylalaninemia is 
characterized by the excretion of 7-substituted pterins 
in urine of patients, e. g. the 7-L-analogue of L-bio-
pterin (L-primapterin), the 7-D- or L-analogue of D-
neopterin (D- or L-anapterin), and 6-oxo-7-L- or D-
analogue of 7-oxo-L-biopterin (6-oxo-L- or D-pri-
mapterin) (1, 2). 
The structure elucidation of the 7-substituted pterins 
was performed using GC-MS, oxidation to their 7-
carboxylic acids, and comparison with reference sub-
stances (1, 3). The determination of the absolute con-
figuration of excreted primapterin belonging to the 
L-series like its 6-analogue was done by CD-meas-
urement (4). Both, L-primapterin and D- or L-ana-
pterin were identified in control urines, blood and in 
liver of man and mouse (3, 5), but only in very small 
amounts. 
The excretion of 7-substituted pterins seems to be 
associated with an enzyme defect in the aromatic 
amino acid hydroxylating system. In vivo formation 
of 7-substituted pterins was achieved incubating their 
fully rcduced 6-analogues with pterin-4a-carbinolam-
inc dehydratase-free rat or human phenylalanine hy-
droxylase (6, 7). It was concluded that the patients 
most probably suffer from a pterin-4a-carbinolamine 
dehydratase (PCDH) deficiency (6). 
From the finding that in vitro the 7-D- or L-analogue 
of D-neopterin originates f rom its 6-tetrahydro ana-
logue by incubating D-NH 4 with dehydratase-free 
phenylalanine hydroxylase, one might speculate that 
in vivo D-tetrahydroncopterin also acts as cofactor 
for the pterin dependent aromatic amino acid hy-
droxylases. This might be the reason for the occur-
rence of D- or L-anapterin in the urine of patients 
and controls. 
In this study we show that D-NH 2 is a substrate for 
D H F R and can be transformed to D-NH 4 which 
possibly could also be a cofactor for the aromatic 
amino acid hydroxylases in vivo. Further we provide 
direct GC-MS evidence for the structure of in vitro 
formed L-primapterin. We could give an explanation 
for the hyperphenylalaninemia of these primapterin-
uric patients. 
Methods 
Pterins were oxidized with manganese dioxide under 
acidic conditions [8], They were analyzed by reverse-
phase HPLC with fluorescence detection (excitation/ 
emission wavelengths were 350/450 nm). Inhibition 
experiments with dehydratase-free rat liver phenylal-
anine hydroxylase were performed in 0.1 M Tris-HCl, 
with 0.35 U phenylalanine hydroxylase (specific activ-
ity 8.5 U/mg protein), 1 m M L-phenylalanine, and an 
excess of both catalase and D H P R , 5 mM N A D H , L-
tetrahydrobiopterin (L-BH4) as substrate (concentra-
tions from 5 to 20 μΜ) and L-tetrahydroprimapterin 
as potential inhibitor (concentrations f rom 2 to 
30 μΜ). For GC-MS measurements of the in vitro 
formed L-primapterin we used a VG-Ì6F single-fo-
cusing magnetic-field instrument according to the 
method of Küster et al. (9). 
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Results and Discussion 
Structure elucidation of in vitro formed L-primapterin 
The identiy of L-primapterin was confirmed by GC-
MS as TMS derivative. For GC a glass capillary 
column was used. Under the GC conditions used the 
silyl derivatives of the two isomers are clearly sepa-
rated (see Fig. 1). 
The mass spectra of both peaks were essentially iden-
tical and were confirmed using chemically synthesized 
L-biopterin and L-primapterin. The signal at m/z 409 
corresponds to the pterin nucleus (Fig. 1) when the 
Y-2' bond of the L-primapterin side-chain is cleaved 
and a proton of the 3'-methyl group shifts to the 6-
position of the pyrazine ring [9]. GC-MS data ob-
tained of in vitro formed L-primapterin give conclu-
sive evidence for the proposed structure. 
Inhibition of phenylalanine hydroxylase 
The reason for transient hyperphenylalaninemia of 
primapterinuric patients has for a long time been a 
puzzling problem. L-tetrahydroprimapterin might in-
hibit phenylalanine hydroxylase activity, resulting in 
an increase of plasma phenylalanine. We showed that 
L-tetrahydroprimapterin competes with L-BH4 for 
the active site of the enzyme (Fig. 2). The K¡ value of 
8 μΜ obtained for L-tetrahydroprimapterin compares 
to Km values of 20 μΜ and 1.5 μΜ, respectively, for 
L-tetrahydroprimapterin and L-BH4 as substrates. 
This observation strongly suggests that in these pa-
tients phenylalanine hydroxylase is inhibited by their 
own abnormal metabolites, the 7-substituted tetra-
hydropterins, resulting in hyperphenylalaninemia. 
The group of Davis et al. (10) states another reason 
for the hyperphenylalaninemia of these patients: L-
tetrahydroprimapterin might be an inefficient cofac-
tor of the phenylalanine hydroxylase and the oxida-
tion of the pterin cofactor would not be coupled to 
the amino acid hydroxylation. 
Nevertheless, primapterinuric patients excrete less L-
BH4 compared to controls (about 40% of urinary L-
biopterin in tetrahydroform compared to 60 — 80% 
in controls). Still, there should be enough cofactor 
present, especially because regeneration of cofactor 
with DHPR was not found to be inhibited by 7-
substituted pterins. 
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Figure 1. Gas-chromatographic analysis of derivatized L-biopterin and L-primapterin, and MS fragmentation pattern of L-
primapterin. The insert represents the GC-MS TIC profile and the figure the electron impact mass spectra of the peak corresponding 
to L-primapterin. 
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Figure 2. Inhibition of the phenylalanine hydroxylase reaction by L-tetrahydroprimapterin. Determination of inhibition type. 
Lineweaver Burke plot at varying concentrations of inhibitor: 0 μΜ up to 20 μΜ L-tetrahydroprimapterin. 
D-Tetrahydroneopterin as cofactor in vivo 
As the 7-D- or L-isomer of D-neopterin is also ex-
creted in the urine of primapterinuric patients as well 
as in control urine one can speculate that other te-
trahydropterins than L-BH4 temporarily act as cofac-
tors and that the need for them varies at different 
stages of development. A metabolic intermediate in 
BH4 biosynthesis is D-tetrahydroneopterin triphos-
phate a compound that is present in substantial con-
centrations in body fluids. The phosphate group can 
be hydrolysed by the action of phosphorylases. 
D H F R , which accepts a variety of substrates, may 
also reduce D-NH 2 to its biologically active tetrahy-
droform. In vitro we found substantial concentrations 
of D-tetrahydroneopterin after incubation of D-di-
hydroneopterin with dihydrofolate reductase in vitro. 
Since in vitro D-tetrahydroneopterin is a cofactor of 
phenylalanine hydroxylase, and in spite of the fact 
that the activity is only 20% compared with L-BH4, 
this pterin might play an important role in patients 
with 6-pyruvoyl tetrahydropterin synthase deficiency. 
These patients excrete increased amounts of D-neo-
pterin but very low levels of L-biopterin D-tetrahy-
droneopterin might thus act as cofactor for the aro-
matic amino acid hydroxylases. Here we might have 
an explanation for the finding that these patients have 
low but nevertheless substantial levels of the neuro-
transmitters deopamine and serotonin in tissues and 
bodyfluids. 
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